scispace - formally typeset
B

Bregje van Oorschot

Researcher at University of Amsterdam

Publications -  8
Citations -  164

Bregje van Oorschot is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Prostate cancer & Toxicity. The author has an hindex of 7, co-authored 8 publications receiving 136 citations.

Papers
More filters
Journal ArticleDOI

Reduced Activity of Double-Strand Break Repair Genes in Prostate Cancer Patients With Late Normal Tissue Radiation Toxicity

TL;DR: Gene expression profiling and DNA DSB repair kinetics data imply that less-efficient repair of radiation-induced DSBs may contribute to the development of late normal tissue damage.
Journal ArticleDOI

Targeting DNA double strand break repair with hyperthermia and DNA-PKcs inhibition to enhance the effect of radiation treatment.

TL;DR: In this paper, the effect of DNA double-strand-break repair with hyperthermia (HT) and DNA-PKcs inhibitor NU7441 (DN) was investigated in cervical and breast cancer cells.
Journal ArticleDOI

Predicting Radiosensitivity with Gamma-H2AX Foci Assay after Single High-Dose-Rate and Pulsed Dose-Rate Ionizing Irradiation.

TL;DR: In this article, the authors investigated the induction and decay of γ-H2AX foci of different tumor cell lines and fibroblasts with known mutations in DNA damage repair genes, including ATM, LigIV, DNA-PKcs, Rad51 and Rad54.
Journal ArticleDOI

Decay of γ-H2AX foci correlates with potentially lethal damage repair in prostate cancer cells.

TL;DR: A clear correlation was demonstrated between the degree of decay of γ-H2AX foci and PLDR and the LNCaP cells which demonstrated a clear PLDR also showed the largest decay in the number of €foci, while the PC cells which did not show PLDR had the lowest decay.
Journal ArticleDOI

Prostate cancer patients with late radiation toxicity exhibit reduced expression of genes involved in DNA double strand break repair and homologous recombination.

TL;DR: Evidence of prognostic utility in prostate cancer for γ-H2AX foci decay ratios and gene expression profiles derived from ex vivo-irradiated patient lymphocytes is reported, suggesting a prognostic biomarker for cancer patients with a genetically enhanced risk for late radiation toxicity to normal tissues after radiotherapy.